A multicenter, double-blind, placebo-randomized controlled clinical study on the treatment of non-alcoholic steatohepatitis with Tibetan drug Langqing Atta Trials

A multicenter, double-blind, placebo-randomized controlled clinical study on the treatment of non-alcoholic steatohepatitis with Tibetan drug Langqing Atta	Welcome, Profile Billing Logout

A multicenter, double-blind, placebo-randomized controlled clinical study on the treatment of non-alcoholic steatohepatitis with Tibetan drug Langqing Atta

Welcome, Profile Billing Logout

0 Trials

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Shpei, LI

NCT06193629: A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar

Recruiting

N/A

150

RoW

Lang Qingata, placebo

Shupei Li

NASH

12/24

NCT06091735: Clinical Study of Bowel Preparation Before Colonoscopy

Completed

N/A

444

RoW

OSS, Sodium potassium magnesium sulfate oral concentrated solution, OSS+Linzess, sodium potassium magnesium sulfate oral concentrated solution + linaclotide, PEG-Interferon Alfa, PEG

Jinling Hospital, China

Bowel Preparation

02/24